NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 94 filers reported holding NEXTCURE INC in Q1 2021. The put-call ratio across all filers is 2.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473,206 | -28.4% | 366,826 | -0.0% | 0.00% | -50.0% |
| Q2 2023 | $660,508 | +14.9% | 366,949 | -5.6% | 0.00% | +100.0% |
| Q1 2023 | $575,082 | +4.8% | 388,569 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $548,518 | -62.0% | 389,020 | -26.0% | 0.00% | -50.0% |
| Q3 2022 | $1,445,000 | -41.5% | 525,406 | +0.0% | 0.00% | -42.9% |
| Q2 2022 | $2,469,000 | -3.3% | 525,335 | -0.0% | 0.01% | +16.7% |
| Q1 2022 | $2,554,000 | -19.0% | 525,572 | +0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,153,000 | -11.2% | 525,540 | -0.3% | 0.01% | -14.3% |
| Q3 2021 | $3,552,000 | -13.3% | 526,985 | +3.3% | 0.01% | -12.5% |
| Q2 2021 | $4,098,000 | +11952.9% | 510,283 | +16424.7% | 0.01% | – |
| Q4 2020 | $34,000 | +3300.0% | 3,088 | +3712.3% | 0.00% | – |
| Q3 2020 | $1,000 | -100.0% | 81 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $2,394,000 | – | 111,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |